Philip Krause

Dr. Philip Krause is an American biotechnology consultant based in Bethesda, Maryland. He is the former Deputy Director of the Office of Vaccines Research & Review at the Food and Drug Administration (FDA).

Krause is a member of the International Council for Harmonisation (ICH)'s Working Group for E8(R1) (Guideline on General Considerations for Clinical Studies).¹⁾ He began his first term as a member of the Scientific Advisory Committee for the Coalition for Epidemic Preparedness Innovations (CEPI) in mid-2019.²⁾

Krause participated in a February 11-12, 2020 event titled “2019 novel Coronavirus Global research and innovation forum: towards a research roadmap” co-hosted by the World Health Organization R&D Blueprint and Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R). He and Anuradha Poonepalli presented on the topic of “Candidate vaccines R&D”.³⁾

Krause was appointed Chair of the WHO R&D Blueprint COVID-19 Vaccines Working Group upon its creation in April 2020.⁴⁾ He participated in the 2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions on June 10, 2021.⁵⁾

Krause began his second term on CEPI's Scientific Advisory Committee in June 2021.⁶⁾

In August 2021, Krause and his superior, Marion Gruber, announced they would be departing their leadership roles at the Food and Drug Administration's Office of Vaccines Research & Review as a result of pressure from the Joe Biden White House to push ahead with COVID-19 vaccine booster doses.⁷⁾

He joined Adjuvance Technologies as a consultant in January 2022,⁸⁾ and Mesoblast in March 2022.⁹⁾

• LinkedIn